logo
Everything to know about cystic fibrosis and what causes it

Everything to know about cystic fibrosis and what causes it

USA Today10-02-2025
Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease and IBS negatively impact countless millions more.
The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in the U.S. currently have it, "though this is likely an underestimate as many patients may have mild forms of the condition and remain undiagnosed," says Dr. Ashwin Basavaraj, system chief of pulmonary medicine at NYC Health + Hospitals.
Here's what cystic fibrosis is, what causes it and how it's usually treated once it has been diagnosed.
What is cystic fibrosis (CF) disease?
Cystic fibrosis (CF) is a progressive genetic disease that adversely affects a person's lungs, pancreas and other vital organs, says Dr. Michael Boyle, president and CEO of the Cystic Fibrosis Foundation in Bethesda, Maryland. The disease impacts the lungs by clogging airways with sticky, thick mucus, which traps bacteria and other germs and sometimes leads to inflammation, respiratory infections and even respiratory failure.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
The buildup of mucus in the pancreas can also prevent the release of digestive enzymes that help the body absorb food, "leading to digestive abnormalities, malnutrition and stunted growth," says Basavaraj.
Other common symptoms of CF include coughing attacks (often with phlegm), shortness of breath, greasy and bulky stools, rectal prolapse and constipation. "People with CF are also more susceptible to sinus and respiratory infections and often require persistent use of antibiotics, leading to concerns over antibiotic resistance," adds Boyle.
CF can also affect the liver, sometimes causing liver disease, as well as impact the reproductive system, sometimes "causing infertility in men," says Basavaraj.
Did you see this?Nearly 1 in 10 Americans have asthma. Here's what causes it.
What causes cystic fibrosis? Is cystic fibrosis genetic?
Cystic fibrosis is caused by mutations in a gene known as the cystic fibrosis transmembrane conductance regulator (CFTR), says Basavaraj. He explains that these mutations eventually cause a protein imbalance and water and salt in the body's cells to surface, "resulting in mucus becoming thick and sticky, and difficulty clearing airways and other organs."
In other words, people with CF are born with the disease, inheriting a copy of this gene from each parent, says Boyle.
In case you missed:At 25 she found out she had the breast cancer gene. Now, she's grieving motherhood.
How is cystic fibrosis treated?
While there is no cure for CF, there are multiple treatment options. Basavaraj says such options include bronchodilators to help open airways; mucus-thinning medications to help clear up the sticky substance; high-frequency chest wall oscillation (HFCWO) devices to help clear mucus from the lungs; and pancreatic enzymes to help with digestion and nutrient absorption.
Moreover, "there are currently five FDA-approved CFTR modulator oral therapies on the market that each address the underlying cause of cystic fibrosis," adds Boyle. These were developed to be effective against specific mutations and more modulator therapies are in development.
Despite the many advantages these therapies provide, "approximately 10% of individuals cannot benefit from modulators due to their genetic mutations or ability to tolerate the treatment," says Boyle. Because of this, he says, "many people living with CF are still waiting for their breakthrough, which is why we are urgently pursuing efforts to ensure there are treatments available to them."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tropicale Foods recalls 14 ice cream products due to undeclared milk: See list
Tropicale Foods recalls 14 ice cream products due to undeclared milk: See list

USA Today

time10 hours ago

  • USA Today

Tropicale Foods recalls 14 ice cream products due to undeclared milk: See list

Over a dozen ice cream snacks have been recalled due to undeclared milk in the products, according to the Canadian company that makes the products. Tropicale Foods has issued recalls for 14 products sold under brand names La Michoacana and Helados Mexico. The company announced the issue on July 25, and the U.S. Food and Drug Administration shared the announcement the following day. The products were sold at retail locations nationwide. USA TODAY has reached out to Tropicale Foods to find out which retailers sell the products. "These products contain undeclared milk," Tropicale Foods said in its statement. "Though these products include 'cream' in the product ingredient lists, the common name 'milk' is not declared." This could lead to serious or life-threatening allergic reactions for those within allergies or severe sensitivities to milk, the company said. According to the announcement, the company conducted an audit of all product labels, leading to the recall. One consumer illness has been reported, the company said. Yogurt recall: YoCrunch products pulled over possible 'plastic pieces' in topper Which products are part of the recall? According to the announcement, the recall applies to products with specific expiration dates, including: What to do if you have the recalled products Those who have the products should throw them away if they have allergies or sensitivities to milk, the announcement said. Customers who have questions can call (909) 563-3090 between 8 a.m. and 5 p.m. PT Monday to Friday. Saleen Martin is a reporter on USA TODAY's NOW team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@

One meal a day. $20 for an egg. Choosing which kid gets fed. Starvation stalks Gaza
One meal a day. $20 for an egg. Choosing which kid gets fed. Starvation stalks Gaza

USA Today

time10 hours ago

  • USA Today

One meal a day. $20 for an egg. Choosing which kid gets fed. Starvation stalks Gaza

One meal a day. Forced to choose which of her kids get fed. In the market, because all the banks are closed and there is a cash liquidity crisis, $20 for a single egg; $1,400 for a bag of flour that might last 20 days. Such is the plight of Gazans like Amal Nassar, 35, an English teacher from Deir Al-Balah, in the central part of the Palestinian enclave. Nassar, her three children and husband are among more than 2 million Gazans who remain trapped almost two years since the war that began after Hamas attacked Israel on Oct. 7, 2023. "We don't have enough to eat," Nassar said in a WhatsApp message over the weekend. USA TODAY previously wrote about Nassar's story of giving birth to her daughter Mira in a war zone without access to pain relief. On July 28, for the second day running, Israel paused its military operations in Gaza to "improve the humanitarian response." That follows a series of alarming warnings from world leaders and global officials, from the United Nations' World Health Organization, and from dozens of humanitarian agencies that malnutrition and even starvation in Gaza is on a "dangerous trajectory." Israel-Gaza: What to know Gaza as starvation spreads The United Nations' World Food Programme says a third of Gaza's population does not eat for several days at a time. Every one in four Gazans, it says, is "enduring famine-like conditions." The Hamas-run health ministry, the chief source of health data in Gaza, says more than 100 people have died from malnutrition in recent days. Israel refutes claims that it is intentionally starving Gaza Israel refutes all claims that it is intentionally starving Gaza's population. It accuses the United Nations of failing to collect and distribute aid sitting on Gaza's border. For nearly two years, it has also accused Hamas of stealing aid for Gaza's desperate and hungry population and using it as a weapon of control. "There is no policy of starvation in Gaza, and there is no starvation in Gaza," Israeli Prime Minister Benjamin Netanyahu said on July 28. He called suggestions there is a "bold-faced lie," prompting a response from President Donald Trump while he was on a golf trip in Scotland. "From what I see on TV, I can say those kids look starving," Trump said. ''We're sending a lot of money and a lot of food. The children in Gaza must receive food and security immediately." Pregnant in Gaza: women face starvation, no anesthesia Going hungry in Gaza Recent reports indicate there's not much evidence of systematic Hamas aid theft. Amid growing international pressure, Israel has also allowed the United Arab Emirates and Jordan to resume aid drops of flour, sugar and canned foods over Gaza. But aid workers say that tactic is not as effective as convoys of trucks. Even large transport planes can't carry as much aid as truck convoys. They can also be dangerous. It's not uncommon for aid drop from planes to injure or even kill those who are trying to get to them. "We need more food to be able to enter Gaza," said Beckie Ryan, the Gaza response director for CARE, an aid group. Ryan is in Deir Al-Balah. CARE runs a health clinic there. She said "everyone is hungry." She also said her clinic has seen a spike in cases of children who are either malnourished or acutely malnourished, and that soaring summer temperatures combined with limited water supplies are exacerbating the situation. Ryan also said cases like Nassar's were fairly typical in Gaza right now. Most people are limited to one meal a day. They are having to chose which of their children gets food. Because no cash has been allowed into Gaza for almost two years, and markets only accept cash, those who are still lucky enough to be earning a salary are having to pay as much as double to effectively buy the cash they need to pay for the limited goods for sale. Ryan said there are "multiple layers" that explain why it's been so hard to get food to Gazans. However, she said the most important thing is "access to the thousands of trucks that are sitting in Egypt and Jordan. It's the quickest and most efficient way. Right now our ability to move those trucks is extremely limited." For Nasser, where the food comes from or who's to blame for the lack of it is of secondary importance. She said she and her husband don't dare go near aid distribution centers run the Gaza Humanitarian Foundation (GHF), an American contractor. They are too scared. It is backed by the United States and Israel but not the United Nations. The international body has reported hundreds of deaths of Palestinians trying to access these centers. Some of those deaths have been linked, by the United Nations, to Israeli gunfire and shelling. GHF has accused the United Nations of "false and exaggerated statistics" over these deaths. Nasser said that weeks can go by without her family eating a single piece of fresh fruit or a vegetable. She said that one diaper for her daughter, Mira, can cost as much as $10 with the extra fees for cash. She uses plastic bags when she can't afford diapers but they give Mira rashes that bleed. She said she constantly worries about her children. They are losing weight. She herself is newly pregnant, exhausted and often feels dizzy. "Our situation," she said, "is really horrible."

ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer
ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer

Business Wire

time12 hours ago

  • Business Wire

ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer

NORFOLK, Va.--(BUSINESS WIRE)-- ReAlta Life Sciences, Inc. ('ReAlta' or the 'Company'), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute inflammatory diseases, today announced the appointment of Ellen Lubman, MBA as Chief Business Officer. In this role, Ms. Lubman will oversee business development, capital formation and corporate strategy. 'Ellen is a highly respected executive with a strong track record of building partnerships, raising capital, and developing successful corporate strategies for biotech and pharmaceutical companies,' said David Marek, Chief Executive Officer of ReAlta. 'We are excited to welcome Ellen at such a pivotal moment for our business with all three clinical programs reading out this year. Her deep strategic and transactional expertise strengthens our team, and she will play a key leadership role as we forge partnerships with pharmaceutical companies and investors alike to advance our transformative therapies for patients across numerous severe inflammatory diseases with high unmet need.' 'I am thrilled to join ReAlta and build on the company's accomplishments in developing the EPICC platform and its lead asset pegtarazimod, which has the potential for clarity this year on a path to approval in hypoxic ischemic encephalopathy (HIE), a devastating disease where no pharmacologic treatment exists,' said Ms. Lubman. 'It is a privilege to contribute to the advancement of this differentiated approach to support the delivery of innovative therapies treating neuroinflammation in newborns with HIE, acute graft-versus-host disease (aGvHD), and acute Chronic Obstructive Pulmonary Disease (COPD).' Ms. Lubman brings seasoned leadership and broad experience across small to large-cap private and public biopharmaceutical companies, with a strong track record in strategic, transactional, and operational roles to ReAlta. She joins ReAlta from Werewolf Therapeutics where she was Chief Business Officer, ushering the company through multiple financings, including an Initial Public Offering, as well as business development transactions. Prior to Werewolf, she was Chief Business Officer of Impel Pharmaceuticals and Vice President of External Science & Innovation at Allergan, where she was responsible for strategic expansion of the company's diverse pipeline of therapeutics in a variety of disease areas. Ms. Lubman has held numerous other executive and leadership roles at Kadmon Pharmaceuticals, Bristol Myers Squibb, Celtic Pharma Management, L.P., Robertson Stephens Investment Bank, and Abbott Labs. She serves on the Board of Directors of Reunion Neuroscience and Cytovation ASA and is a Strategic Advisor to Two Bear Capital. Ms. Lubman earned her M.B.A. from Stanford Graduate School of Business with a focus on Global Management and her B.A. in Biology from Rutgers College. About ReAlta Life Sciences ReAlta Life Sciences, Inc. is a clinical mid-stage biopharmaceutical company dedicated to addressing life threatening rare and acute inflammatory diseases by rebalancing the inflammatory response. The Company's EPICC peptide platform leverages discoveries from the human astrovirus (HAstV-1), which uniquely inhibits components of the innate immune system. ReAlta's therapeutic peptides employ the dual-targeting mechanisms of HAstV-1 to modulate both complement and innate inflammatory pathways by inhibiting complement cascade activation and two key neutrophil-driven mechanisms: myeloperoxidase (MPO) and neutrophil extracellular traps (NETs). The Company's lead candidate, RLS-0071 (pegtarazimod), has received FDA Orphan Drug Designation and Fast Track Designations for hypoxic ischemic encephalopathy (HIE), a devastating disease that causes brain damage and high mortality in oxygen-deprived newborns; Orphan Drug Designation by the European Medicines Agency for HIE; FDA Orphan Drug and Fast Track Designations for acute graft-versus-host disease (aGvHD) associated with bone marrow and stem cell transplants; and FDA IND clearance for acute exacerbations of chronic obstructive pulmonary disease (COPD). Founded in 2018, ReAlta operates in Norfolk, Virginia and Aguadilla, Puerto Rico. For more information, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store